211 related articles for article (PubMed ID: 26169126)
1. The 2',4'-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species.
Passalacqua TG; Torres FA; Nogueira CT; de Almeida L; Del Cistia ML; dos Santos MB; Dutra LA; Bolzani VS; Regasini LO; Graminha MA; Marchetto R; Zottis A
Bioorg Med Chem Lett; 2015 Sep; 25(17):3564-8. PubMed ID: 26169126
[TBL] [Abstract][Full Text] [Related]
2. The chemotherapeutic potential of chalcones against leishmaniases: a review.
Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
[TBL] [Abstract][Full Text] [Related]
3. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
4. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.
Ogungbe IV; Ng JD; Setzer WN
Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones.
Aponte JC; Castillo D; Estevez Y; Gonzalez G; Arevalo J; Hammond GB; Sauvain M
Bioorg Med Chem Lett; 2010 Jan; 20(1):100-3. PubMed ID: 19962891
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-
Mendes EP; Goulart CM; Chaves OA; Faiões VDS; Canto-Carvalho MM; Machado GC; Torres-Santos EC; Echevarria A
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652866
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes.
de Mesquita Barbosa A; Dos Santos Costa S; da Rocha JR; Montanari CA; Giorgio S
Biomed Pharmacother; 2015 Aug; 74():95-100. PubMed ID: 26349969
[TBL] [Abstract][Full Text] [Related]
9. Virtual and experimental screening of phenylfuranchalcones as potential anti-Leishmania candidates.
Ochoa R; García E; Robledo SM; Cardona G W
J Mol Graph Model; 2019 Sep; 91():164-171. PubMed ID: 31252366
[TBL] [Abstract][Full Text] [Related]
10. Molecular Targets for Chalcones in Antileishmanial Drug Discovery.
de Santiago-Silva KM; da Silva Gomes GF; Perez CC; da Silva Lima CH; de Lima Ferreira Bispo M
Mini Rev Med Chem; 2023; 23(14):1414-1434. PubMed ID: 36705240
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
Gomes MN; Alcântara LM; Neves BJ; Melo-Filho CC; Freitas-Junior LH; Moraes CB; Ma R; Franzblau SG; Muratov E; Andrade CH
Bioorg Med Chem Lett; 2017 Jun; 27(11):2459-2464. PubMed ID: 28434763
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.
Holanda VN; Silva WVD; Nascimento PHD; Silva SRB; Cabral Filho PE; Assis SPO; Silva CAD; Oliveira RN; Figueiredo RCBQ; Lima VLM
Bioorg Chem; 2020 Dec; 105():104437. PubMed ID: 33339081
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of chalcone derivatives as antileishmanial agents.
de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
[TBL] [Abstract][Full Text] [Related]
15. Brazilian brown propolis elicits antileishmanial effect against promastigote and amastigote forms of Leishmania amazonensis.
Santana LC; Carneiro SM; Caland-Neto LB; Arcanjo DD; Moita-Neto JM; Citó AM; Carvalho FA
Nat Prod Res; 2014; 28(5):340-3. PubMed ID: 24261482
[TBL] [Abstract][Full Text] [Related]
16. Chalcones identify cTXNPx as a potential antileishmanial drug target.
Escrivani DO; Charlton RL; Caruso MB; Burle-Caldas GA; Borsodi MPG; Zingali RB; Arruda-Costa N; Palmeira-Mello MV; de Jesus JB; Souza AMT; Abrahim-Vieira B; Freitag-Pohl S; Pohl E; Denny PW; Rossi-Bergmann B; Steel PG
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009951. PubMed ID: 34780470
[TBL] [Abstract][Full Text] [Related]
17. Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.
da Silva ER; Brogi S; Grillo A; Campiani G; Gemma S; Vieira PC; Maquiaveli CDC
Chem Biol Drug Des; 2019 Feb; 93(2):139-146. PubMed ID: 30216691
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T
Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628
[TBL] [Abstract][Full Text] [Related]
19. trans-Chalcone modulates Leishmania amazonensis infection in vitro by Nrf2 overexpression affecting iron availability.
Miranda-Sapla MM; Tomiotto-Pellissier F; Assolini JP; Carloto ACM; Bortoleti BTDS; Gonçalves MD; Tavares ER; Rodrigues JHDS; Simão ANC; Yamauchi LM; Nakamura CV; Verri WA; Costa IN; Conchon-Costa I; Pavanelli WR
Eur J Pharmacol; 2019 Jun; 853():275-288. PubMed ID: 30965057
[TBL] [Abstract][Full Text] [Related]
20. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
